• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

小分子药物在对抗艰难梭菌方面取得重大进展。

Small Molecules Take A Big Step Against Clostridium difficile.

机构信息

Molecular Structure & Function, The Hospital for Sick Children, 686 Bay Street, Toronto, ON M5G 0A4, Canada.

Molecular Structure & Function, The Hospital for Sick Children, 686 Bay Street, Toronto, ON M5G 0A4, Canada; Department of Biochemistry, University of Toronto, Toronto, ON M5S 1A8, Canada.

出版信息

Trends Microbiol. 2015 Dec;23(12):746-748. doi: 10.1016/j.tim.2015.10.009. Epub 2015 Nov 5.

DOI:10.1016/j.tim.2015.10.009
PMID:26547239
Abstract

Effective treatment of Clostridium difficile infections demands a shift away from antibiotics towards toxin-neutralizing agents. Work by Bender et al., using a drug that attenuates toxin action in vivo without affecting bacterial survival, demonstrates the exciting potential of small molecules as a new modality in the fight against C. difficile.

摘要

有效治疗艰难梭菌感染需要从抗生素转向毒素中和剂。Bender 等人的研究使用了一种药物,该药物在不影响细菌存活的情况下减弱毒素的作用,证明了小分子作为一种对抗艰难梭菌的新方法具有令人兴奋的潜力。

相似文献

1
Small Molecules Take A Big Step Against Clostridium difficile.小分子药物在对抗艰难梭菌方面取得重大进展。
Trends Microbiol. 2015 Dec;23(12):746-748. doi: 10.1016/j.tim.2015.10.009. Epub 2015 Nov 5.
2
A small-molecule antivirulence agent for treating Clostridium difficile infection.一种用于治疗艰难梭菌感染的小分子抗毒力剂。
Sci Transl Med. 2015 Sep 23;7(306):306ra148. doi: 10.1126/scitranslmed.aac9103.
3
Synthesis and SAR studies of novel benzodiazepinedione-based inhibitors of Clostridium difficile (C. difficile) toxin B (TcdB).艰难梭菌(C. difficile)毒素B(TcdB)新型苯并二氮杂卓二酮类抑制剂的合成与构效关系研究
Bioorg Med Chem Lett. 2018 Dec 15;28(23-24):3601-3605. doi: 10.1016/j.bmcl.2018.10.047. Epub 2018 Oct 29.
4
Acyldepsipeptide antibiotics as a potential therapeutic agent against Clostridium difficile recurrent infections.酰基缩酚肽类抗生素作为一种抗艰难梭菌复发性感染的潜在治疗药物。
Future Microbiol. 2016 Sep;11:1179-89. doi: 10.2217/fmb-2016-0064. Epub 2016 Aug 22.
5
Inhibitory Effect of Epigallocatechin Gallate on the Virulence of Clostridium difficile PCR Ribotype 027.表没食子儿茶素没食子酸酯对艰难梭菌PCR核糖型027毒力的抑制作用
J Food Sci. 2015 Dec;80(12):M2925-31. doi: 10.1111/1750-3841.13145. Epub 2015 Nov 10.
6
Therapy for Clostridium difficile infection - any news beyond Metronidazole and Vancomycin?艰难梭菌感染的治疗——除了甲硝唑和万古霉素之外还有什么新进展吗?
Expert Rev Clin Pharmacol. 2017 Nov;10(11):1239-1250. doi: 10.1080/17512433.2017.1362978. Epub 2017 Aug 11.
7
Nonantimicrobial drug targets for Clostridium difficile infections.艰难梭菌感染的非抗菌药物靶点
Future Microbiol. 2017 Sep;12(11):975-985. doi: 10.2217/fmb-2017-0024. Epub 2017 Jul 31.
8
Clostridium difficile infection: New insights into therapeutic options.艰难梭菌感染:治疗选择的新见解
Crit Rev Microbiol. 2016 Sep;42(5):773-9. doi: 10.3109/1040841X.2015.1027171. Epub 2015 May 8.
9
The contribution of strains and hosts to outcomes in Clostridium difficile infection.艰难梭菌感染中菌株和宿主对感染结局的影响。
Infect Dis Clin North Am. 2015 Mar;29(1):51-61. doi: 10.1016/j.idc.2014.11.012. Epub 2015 Jan 9.
10
Clostridium difficile chimeric toxin receptor binding domain vaccine induced protection against different strains in active and passive challenge models.艰难梭菌嵌合毒素受体结合域疫苗在主动和被动攻击模型中诱导了针对不同菌株的保护作用。
Vaccine. 2017 Jul 24;35(33):4079-4087. doi: 10.1016/j.vaccine.2017.06.062. Epub 2017 Jun 29.

引用本文的文献

1
Caffeic acid phenethyl ester protects infection by toxin inhibition and microbiota modulation.咖啡酸苯乙酯通过毒素抑制和微生物群调节来预防感染。
Elife. 2025 Jun 11;13:RP101757. doi: 10.7554/eLife.101757.
2
Small Molecule Attenuates Bacterial Virulence by Targeting Conserved Response Regulator.小分子通过靶向保守反应调节剂来减弱细菌毒力。
mBio. 2023 Jun 27;14(3):e0013723. doi: 10.1128/mbio.00137-23. Epub 2023 Apr 19.
3
Host-targeted niclosamide inhibits C. difficile virulence and prevents disease in mice without disrupting the gut microbiota.
靶向宿主的尼氯硝唑抑制艰难梭菌的毒力,防止小鼠发病,而不破坏肠道微生物群。
Nat Commun. 2018 Dec 7;9(1):5233. doi: 10.1038/s41467-018-07705-w.
4
Reactive Oxygen Species as Additional Determinants for Cytotoxicity of Clostridium difficile Toxins A and B.活性氧作为艰难梭菌毒素A和B细胞毒性的额外决定因素
Toxins (Basel). 2016 Jan 18;8(1):25. doi: 10.3390/toxins8010025.